HRH3 and psychotic disorder: Understanding the molecular structure of the H3R has increased considerably and a number of H3R antagonists have been identified and a few (pitolisant and GSK189254) have entered advanced clinical development focusing on narcolepsy, cognitive and psychotic disorders [8], [18], [19].